An Auburn firm’s anti-moisture and other detrimental conditions technology is helping to protect two new at-home COVID-19 tests.
Aptar CSP’s Activ-Film technology is used in the diagnostic kits to protect against moisture and other conditions that might impact the accuracy of the tests. The diagnostic test kits include Quidel’s QuickVue flu and COVID-19 tests, which are administered at medical facilities.
That same technology is now protecting two at-home COVID-19 tests, which the company says it cannot name.
“As we continue to navigate through the COVID-19 crisis, this game-changing solution will help meet the urgent demand for COVID-19 testing in communities around the world,” said Badre Hammond, vice president commercial operations, Aptar CSP Technologies. “We are committed to leveraging our material science expertise to enable our partners to meet the ongoing need for innovative healthcare solutions that help improve and save lives. This is another example of the value we bring to the market when sensitive diagnostic elements need protection.”
Aptar CSP Technologies is part of Illinois-based AptarGroup Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and material science solutions.
